Evidence map›Paper›PMID 41183278›Full record

ArticleBlood transfusion = Trasfusione del sangue

Innovation in Blood Establishment Processes, Strasbourg, 2025: a Conference Report.

Marie Pflieger, Annika Sepich, Julie Harriague, Margarida Amil, Nigar Ertuğrul Örüç, Tor Audun Hervig, Ína Björg Hjálmarsdóttir, Lene Holm Harritshøj, Luca Mascaretti, Simonetta Pupella and 7 more

Abstract readConference Proceedings
In one paragraph

Article in Blood transfusion = Trasfusione del sangue. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Marie PfliegerEuropean Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, Strasbourg, France.
Annika SepichEuropean Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, Strasbourg, France.
Julie HarriagueP95 Clinical and Epidemiology Services, Leuven, Belgium.
Margarida AmilInstituto Português do Sangue e da Transplantação, Porto, Portugal.
Nigar Ertuğrul ÖrüçBlood Transfusion Centre, University of Health Sciences Diskapı Yildirim Beyazit Training and Research Hospital, Ankara, Türkiye.
Tor Audun HervigStavanger University Hospital, Stavanger, Norway.
Ína Björg HjálmarsdóttirThe Blood Bank, Landspitali University Hospital, Reykjavík, Iceland.
Lene Holm HarritshøjRigshospitalet, Department of Clinical Immunology, Copenhagen Blood Centre, Copenhagen, Denmark.
Luca MascarettiDeputy Editor, Blood Transfusion, Milan, Italy.
Simonetta PupellaNational Blood Centre, Istituto Superiore di Sanità, Rome, Italy.
Harald SchennachCentral Institute for Blood Transfusion and Dept. of Immunology (ZIB), Tirol Kliniken GmbH, Innsbruck, Austria.
Stephen VardyNHS Blood and Transplant, Barnsley, United Kingdom.
Tomislav VukCroatian Institute of Transfusion Medicine, Zagreb, Croatia.
Perrine ArnouldEuropean Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, Strasbourg, France.
Rada M Grubovic RastvorcevaEuropean Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, Strasbourg, France.
Richard FordeEuropean Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, Strasbourg, France.
Marie EmeryEuropean Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, Strasbourg, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report highlights the main topics discussed during the international EDQM Blood Conference on Innovation in Blood Establishment Processes, hosted by the European Directorate for the Quality of Medicines & Healthcare (EDQM) of the Council of Europe in Strasbourg, France on 14-15 January 2025. The shift from the existing European Union (EU) directives to the new Substances of Human Origin (SoHO) Regulation (EU) 2024/1938 in 2027 will allow a more unified approach across the EU. It will establish measures to set high quality and safety standards for SoHO intended for human applications, thus ensuring high levels of health protection for donors and recipients while strengthening the continuity of the supply of critical SoHO. This conference was an opportunity for participants to share and discuss experiences and innovation in blood donation and blood components. It also raised awareness of the benefits and challenges in implementing the new SoHO Regulation in the blood transfusion field.

Indexed as

Blood BanksBlood DonorsBlood SafetyBlood TransfusionFranceHumans

Identifiers

PMID41183278
PMCPMC12860585

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.